Srividya Ramachandran

发表

Potential prophylactic and therapeutic vaccines for HSV infections.

P. Kinchington, Srividya Ramachandran, 2007, Current pharmaceutical design.

Influence of herpes simplex virus type-1 glycoprotein B expression on viral pathogenecity and the CD8+ T cell response

Srividya Ramachandran, 2010 .

Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters.

P. Kinchington, R. Hendricks, J. Knickelbein, 2008, Virology.

Role of Lymphocytic Choriomeningitis Virus (LCMV) in Understanding Viral Immunology: Past, Present and Future

Daniel L. Popkin, D. Popkin, Margaret W. Mann, 2012, Viruses.

Delaying the Expression of Herpes Simplex Virus Type 1 Glycoprotein B (gB) to a True Late Gene Alters Neurovirulence and Inhibits the gB-CD8+ T-Cell Response in the Trigeminal Ganglion

P. Kinchington, R. Hendricks, Michael B Yee, 2010, Journal of Virology.

Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis

M. Diamond, G. Sen, S. Stohlman, 2012, PLoS pathogens.

Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells

P. Kinchington, R. Hendricks, Benjamin R. Treat, 2017, PLoS pathogens.

Delaying the Expression of Herpes Simplex Virus Type 1 Glycoprotein B (gB) to a True Late Gene Alters Neurovirulence and Inhibits the gB-CD8+ T-Cell Response in the Trigeminal Ganglion

P. Kinchington, R. Hendricks, Michael B Yee, 2010, Journal of Virology.